Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. 2005

Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
Department of Dermatology, Ehime University School of Medicine, Ehime 791-0295, Japan. shirakat@m.ehime-u.ac.jp

Members of the epidermal growth factor (EGF) family are the most important growth factors involved in epithelialization during cutaneous wound healing. Heparin-binding EGF-like growth factor (HB-EGF), a member of the EGF family, is thought to play an important role in skin wound healing. To investigate the in vivo function of HB-EGF in skin wound healing, we generated keratinocyte-specific HB-EGF-deficient mice using Cre/loxP technology in combination with the keratin 5 promoter. Studies of wound healing revealed that wound closure was markedly impaired in keratinocyte-specific HB-EGF-deficient mice. HB-EGF mRNA was upregulated at the migrating epidermal edge, although cell growth was not altered. Of the members of the EGF family, HB-EGF mRNA expression was induced the most rapidly and dramatically as a result of scraping in vitro. Combined, these findings clearly demonstrate, for the first time, that HB-EGF is the predominant growth factor involved in epithelialization in skin wound healing in vivo and that it functions by accelerating keratinocyte migration, rather than proliferation.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte

Related Publications

Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
May 2006, The Journal of biological chemistry,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
March 2013, Journal of controlled release : official journal of the Controlled Release Society,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
April 1996, The Journal of investigative dermatology,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
December 2011, The Journal of surgical research,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
December 1997, Biochimica et biophysica acta,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
January 2002, The Journal of burn care & rehabilitation,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
January 1998, The Journal of burn care & rehabilitation,
Yuji Shirakata, and Rina Kimura, and Daisuke Nanba, and Ryo Iwamoto, and Sho Tokumaru, and Chie Morimoto, and Koichi Yokota, and Masanori Nakamura, and Koji Sayama, and Eisuke Mekada, and Shigeki Higashiyama, and Koji Hashimoto
July 1995, Investigative ophthalmology & visual science,
Copied contents to your clipboard!